About GLP-3 Wiki

GLP-3 Wiki is an independent, research-backed reference on retatrutide — Eli Lilly's investigational triple agonist for obesity and type 2 diabetes — and the broader GLP-1 class of weight loss drugs.

We are not affiliated with Eli Lilly, Novo Nordisk, or any pharmaceutical company. Nothing on this site is medical advice. Every article is grounded in published clinical trial data, regulatory filings, or peer-reviewed literature — sourced and linked directly wherever possible.

If you have feedback, a correction, or a source we should cite, see the methodology page for how we review and update content.